ENTITY

Cosmo Pharmaceuticals Sa (COPN SW)

2
Analysis
Health CareLuxembourg
Cosmo Pharmaceuticals SA develops and manufactures therapies for gastrointestinal diseases. The Company's proprietary technology delays the delivery of the active drug mainly into the lumen of the colon. Cosmo develops treatments for inflammatory bowel diseases such as ulcerative colitis and Crohn's disease, and for colon infections.
more
31 Jul 2020 08:59

EM Equities At New Highs Despite Some Caution Signs

We continue to believe the path of least resistance is higher for global equities. As a result, our outlook remains bullish and we suggest buying...

Logo
346 Views
Share
bullishMSCI ACWI Index
24 Jul 2020 08:15

U.S. Dollar Breakdown: Bullish For Ex-U.S. Equities

Global indexes including the MSCI ACWI and ACWI ex-US are following in the MSCI EM index’s footsteps by breaking to new highs. This is bullish and...

Logo
439 Views
Share
No more insights
x